Who Generates More Revenue? Bristol-Myers Squibb Company or Walgreens Boots Alliance, Inc.

Revenue Showdown: Bristol-Myers Squibb vs. Walgreens Boots Alliance

__timestampBristol-Myers Squibb CompanyWalgreens Boots Alliance, Inc.
Wednesday, January 1, 20141587900000076392000000
Thursday, January 1, 201516560000000103444000000
Friday, January 1, 201619427000000117351000000
Sunday, January 1, 201720776000000118214000000
Monday, January 1, 201822561000000131537000000
Tuesday, January 1, 201926145000000120074000000
Wednesday, January 1, 202042518000000121982000000
Friday, January 1, 202146385000000132509000000
Saturday, January 1, 202246159000000132703000000
Sunday, January 1, 202345006000000139081000000
Monday, January 1, 202448300000000147658000000
Loading chart...

In pursuit of knowledge

Revenue Race: Bristol-Myers Squibb vs. Walgreens Boots Alliance

In the ever-evolving landscape of the healthcare and pharmaceutical industries, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, Walgreens Boots Alliance has consistently outpaced Bristol-Myers Squibb in revenue generation. From 2014 to 2023, Walgreens Boots Alliance's revenue surged by approximately 82%, peaking at $139 billion in 2023. In contrast, Bristol-Myers Squibb experienced a more modest growth of around 183%, reaching its highest revenue of $46 billion in 2021.

Despite Bristol-Myers Squibb's impressive growth rate, Walgreens Boots Alliance's revenue remains nearly three times higher, underscoring its dominant position in the market. However, it's worth noting that data for Bristol-Myers Squibb in 2024 is missing, which could impact future comparisons. As these industry giants continue to innovate and expand, their revenue trajectories will be crucial to watch.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025